Best Dermatology Journals (2026): Ranked by Impact and Accessibility
Ranked list of the top 12 dermatology journals by impact factor, acceptance rate, APC, and review speed, covering clinical, investigative, surgical, and open-access dermatology outlets.
Senior Researcher, Oncology & Cell Biology
Author context
Specializes in manuscript preparation and peer review strategy for oncology and cell biology, with deep experience evaluating submissions to Nature Medicine, JCO, Cancer Cell, and Cell-family journals.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Dermatology's journal landscape is unusually diverse for a specialty of its size. The field spans cosmetic procedures, autoimmune skin disease, skin cancer, pediatric dermatology, dermatopathology, and skin biology, and the journals reflect this breadth. Some are clinically oriented and feature heavy photographic content. Others focus on cellular mechanisms and immunology. Knowing where your work fits requires understanding not just impact factors but editorial philosophies.
The field has also undergone significant open access transitions recently. The British Journal of Dermatology moved to a fully OA model, and companion journals like JAAD International and JID Innovations have expanded accessible publishing options. This means more choices for researchers, but also more homework when picking a target.
Quick Answer: Top 5 Dermatology Journals
- JAMA Dermatology (IF ~11.8) for high-impact clinical research
- Journal of the American Academy of Dermatology (JAAD) (IF ~11.5) for clinical dermatology
- Journal of Investigative Dermatology (JID) (IF ~7.5) for basic and translational research
- British Journal of Dermatology (BJD) (IF ~8.1) for international clinical research
- Journal of the European Academy of Dermatology (JEADV) (IF ~5.8) for European clinical work
Full Comparison Table
Journal | IF | Acceptance Rate | APC | Review Time | Scope |
|---|---|---|---|---|---|
JAMA Dermatology | ~11.8 | ~7% | Subscription | 4-8 weeks | Clinical, evidence-based |
JAAD | ~11.5 | ~10% | Subscription | 6-10 weeks | Broad clinical dermatology |
JID | ~7.5 | ~15% | $3,400 (OA option) | 6-10 weeks | Basic and translational |
British Journal of Dermatology | ~8.1 | ~12% | $3,900 (OA) | 6-10 weeks | Clinical and translational |
JEADV | ~5.8 | ~20% | $3,600 (OA option) | 6-10 weeks | European clinical |
Experimental Dermatology | ~3.8 | ~25% | $3,200 (OA option) | 4-8 weeks | Basic science |
Dermatologic Surgery | ~2.5 | ~25% | Subscription | 6-10 weeks | Procedural dermatology |
JAAD International | ~3.2 | ~30% | $2,500 (OA) | 4-6 weeks | Open access clinical |
JID Innovations | ~3.0 | ~30% | $2,600 (OA) | 4-6 weeks | Open access translational |
Acta Dermato-Venereologica | ~4.5 | ~20% | Free OA | 6-10 weeks | Clinical, Scandinavian |
Dermatology | ~3.6 | ~25% | $3,000 (OA option) | 6-10 weeks | Clinical, European |
Clinical and Experimental Dermatology | ~2.1 | ~35% | $2,700 (OA option) | 4-8 weeks | Clinical, educational |
Elite Tier: Top-Impact Dermatology Journals
JAMA Dermatology
Part of the JAMA network, this journal carries enormous prestige and cross-specialty visibility. It publishes clinical trials, large cohort studies, systematic reviews, and health policy research related to skin disease. The editorial process is rigorous, and they're strict about study design and statistical methods. JAMA Dermatology is where practice-changing dermatology research gets published. If your paper has the potential to alter clinical guidelines, start here.
Journal of the American Academy of Dermatology (JAAD)
JAAD is the most widely read dermatology journal in the US. It covers everything from clinical reviews and guidelines to original research and continuing medical education. The journal has a strong clinical orientation and values practical relevance for practicing dermatologists. Your paper doesn't need to be the next landmark trial, but it does need to offer something a clinician can use. JAAD also publishes excellent clinical images and case series that other top journals ignore.
British Journal of Dermatology (BJD)
BJD recently transitioned to fully open access under Wiley, which has changed its dynamics. It remains one of the strongest dermatology journals globally, with a balanced mix of clinical and translational content. The journal has an international author base and doesn't lean as heavily toward UK-specific healthcare issues as you might expect. It's a strong alternative to JAAD for clinical research with good study design.
Journal of Investigative Dermatology (JID)
JID is the premier venue for basic and translational skin science. If your work involves keratinocyte biology, skin immunology, wound healing mechanisms, or genetic skin diseases, JID is the target. It doesn't publish clinical trials or purely observational studies. The review process values mechanistic depth and experimental rigor. This is a researcher's journal, not a clinician's journal.
Strong Tier: Respected and Competitive
JEADV
The Journal of the European Academy of Dermatology and Venereology is the primary European clinical dermatology journal outside of BJD. It publishes clinical studies, reviews, and guidelines with a European perspective. The acceptance rate around 20% makes it more realistic than JAAD or BJD, and the readership is large. It's a strong fit for clinical observational studies and guideline-relevant research.
Experimental Dermatology
This journal focuses on basic science in skin biology. It's more accessible than JID but maintains solid peer review standards. If your basic science paper doesn't quite reach JID's novelty threshold, Experimental Dermatology is a natural next choice. It values well-designed experiments and clear mechanistic conclusions.
Acta Dermato-Venereologica
Acta DV deserves special mention for offering free open access publishing. That's increasingly rare and extremely valuable. The journal is well-indexed, has a stable impact factor, and publishes quality clinical and translational work. It has Scandinavian roots but accepts international submissions. If you want OA without paying thousands in APCs, this is a top option.
Dermatologic Surgery
The go-to journal for procedural dermatology, including Mohs surgery, laser treatments, cosmetic procedures, and surgical techniques. If your research involves surgical outcomes, technique comparisons, or procedural innovations, this is the right home. General dermatology journals won't give procedural work the same attention.
Accessible Tier: Open Access and Broader Options
JAAD International
JAAD's open access companion has grown quickly and now publishes a steady stream of clinical research. It's not a dump for JAAD rejects. It has its own editorial board and review process. The APC is reasonable, and the JAAD brand gives it immediate recognition. Good for well-designed clinical studies that need OA dissemination.
JID Innovations
JID's open access counterpart focuses on translational and basic research. It launched with the goal of publishing scientifically sound work that doesn't necessarily reach JID's impact threshold. It's a natural fallback after JID rejection and a reasonable first-choice for early-career researchers in skin biology.
Clinical and Experimental Dermatology
CED is an accessible option for case reports, small clinical studies, and educational reviews. The acceptance rate is forgiving, and the journal serves as a good training ground for junior researchers. It's indexed in all major databases, and publications here are counted in academic promotion portfolios.
Dermatology
This Basel-based journal publishes a mix of clinical studies and translational work with a European flavor. It's competitive but not impossibly so, and the editorial team is responsive. A good target for mid-range clinical research.
Decision Framework: Choosing Your Target
If your paper is a large clinical trial or cohort study, JAMA Dermatology or BJD should be your first choice. Both prioritize evidence-based clinical research.
If your paper is a clinical review or guideline, JAAD is the best fit. It's the journal practicing dermatologists actually read for clinical guidance.
If your paper is basic science (cell biology, genetics, immunology), JID is the target. For work that doesn't quite reach JID, try Experimental Dermatology.
If your paper is a surgical or procedural study, Dermatologic Surgery is the obvious and best choice.
If your paper needs open access on a budget, Acta Dermato-Venereologica offers free OA. JAAD International and JID Innovations have moderate APCs.
If your paper is a case series or small observational study, Clinical and Experimental Dermatology or JAAD International are realistic targets.
Common Mistakes in Dermatology Journal Selection
Sending basic science to JAAD. JAAD is clinically oriented. If your paper doesn't have direct clinical relevance, JAAD editors won't engage with it. Send mechanism-focused work to JID or Experimental Dermatology.
Ignoring subspecialty journals. Pediatric Dermatology, Dermatologic Surgery, and Contact Dermatitis exist for a reason. Subspecialty journals offer targeted readership that generalist journals can't match.
Overlooking the BJD transition. Since BJD went fully OA, the APC is now mandatory. Factor this into your budget before submitting.
Submitting images without proper quality. Dermatology is a visual specialty. Low-resolution clinical photos will get your paper desk-rejected at image-heavy journals like JAAD.
Not reviewing author guidelines for image formatting. Each journal has specific requirements for clinical photographs, histopathology images, and dermoscopic images. These aren't suggestions.
Polish Your Paper Before Submitting
Dermatology journals are visual, detailed, and demanding. Before submitting, run your manuscript through Manusights' AI review to check for structural issues, statistical concerns, and formatting problems that could trigger a desk rejection. A few minutes of automated review can save you weeks of waiting for feedback you could have anticipated.
Sources
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.